Ilyang Pharmaceutical Co.,Ltd (KRX: 007570)

Ilyang Pharmaceutical Co.,Ltd Revenue

Ilyang Pharmaceutical Co.,Ltd had revenue of 82.70B KRW in the quarter ending June 30, 2024, a decrease of -3.11%. This brings the company's revenue in the last twelve months to 366.05B, down -3.84% year-over-year. In the year 2023, Ilyang Pharmaceutical Co.,Ltd had annual revenue of 370.54B, down -3.46%.

• Revenue (ttm): 366.05B
• Revenue Growth: -3.84%
• P/S Ratio: 0.54
• Revenue / Employee: 562.29M
• Employees: 651
• Market Cap: 199.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	370.54B	-13.27B	-3.46%
Dec 31, 2022	383.81B	12.46B	3.36%
Dec 31, 2021	371.35B	28.02B	8.16%
Dec 31, 2020	343.33B	18.76B	5.78%
Dec 31, 2019	324.57B	24.54B	8.18%